Microsoft Pri0
Welcome to Microsoft Pri0: That's Microspeak for top priority, and that's the news and observations you'll find here from Seattle Times reporter Sharon Chan.
SubscribeNovember 7, 2007 5:18 PM
Potential rival to Enbrel on the horizon
Posted by Angel Gonzalez
An experimental arthritis therapy known as golimumab showed promising results in a late-stage clinical study for the treatment of psoriatic arthritis, Johnson & Johnson unit Centocor and Schering-Plough said Wednesday. The data signals the potential appearance of a new rival to Enbrel, the best-selling treatment developed in Seattle by Immunex and now sold by Amgen.
The compound is designed to be administered less frequently than Enbrel and Abbott Laboratories' Humira (one injection a month, instead of one a week for Enbrel and one every two weeks for Humira). The therapy constitutes an "incremental improvement" over Enbrel and other similar drugs, said Dr. Philip Mease, chief of the Swedish Medical Center's Division of Rheumathology Research in Seattle. Dr. Mease served as an investigator in the trial.
Digg
Newsvine
UPDATE - 4:32 PM
Recently listed
Popular searches
Jul 1, 08 - 11:45 AM
Microsoft buying natural-language search company Powerset
Jun 30, 08 - 05:16 PM
Report: Microsoft to cut Xbox 360 price ahead of big industry event
Jun 27, 08 - 03:52 PM
Gates send-off: Gates has had Ballmer's back from the beginning
Jun 27, 08 - 01:09 PM
Gates send-off: Photos
Jun 27, 08 - 11:48 AM
Gates send-off: Two guys and 90,000 employees
shopping
events for Tuesday, Nov. 24
- Asher Anson Black Friday and December Sales
- Holiday Sale at Pink Ginger
- Clementine's December Daily Sale
- Shenui.com Holiday Sale
editors' picks
- Local jewelry designers
- Maternity shopping
- Vintage, consignment and used clothing
- Independent bookstores
- Illegal workers quietly let go
- Sprouts, raw fish on attorney's 'do not eat' list
- Jerry Brewer | Jerry Brewer: Seahawks can't lean on the Hutch Crutch now
- Woman stabbed by stranger in North Seattle
- Tattoos at Mill Creek church pierce skin, soul
- UW, WSU once again meet to see who's worse
- Food-safety lawyer's wish: Put me out of business
- Husky Football Blog | Ranking the Pac
- Vikings easily beat the Seahawks
- Tugboat sinks at Seattle waterfront pier
- Sprouts, raw fish on attorney's 'do not eat' list
- Tattoos at Mill Creek church pierce skin, soul
- Food-safety lawyer's wish: Put me out of business
- Illegal workers quietly let go
- Architects, chefs find 'kid' within to build Gingerbread Village
- Nicole Brodeur | Homeless woman bent on giving
- Portland cafe's specialty: medical-marijuana tokes
- Hutch gets $10M from Bezos family for immunotherapy research
- Big demand, grim outlook for state Basic Health Plan
- Rediscovering Moab, 'the most beautiful place on Earth'
July
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 |
Bill Gates, who last week ended his full-time involvement with Microsoft, was often right. He made a career, a company and an industry by looking over the horizon.